Indications

We focus on rare respiratory diseases in order to give patients with unmet medical needs better treatment options.

Read more

Pipeline

We are advancing a pipeline of novel inhalation therapies for the treatment of severe pulmonary conditions.

Read more

Clinical trials

Savara is currently conducting clinical trials within the fields of cystic fibrosis (CF) and pulmonary alveolar proteinosis (PAP).

Read more

AeroVanc.com

Visit the AeroVanc website to learn more about MRSA in Cystic Fibrosis, AeroVanc and our upcoming Phase III clinical study

Read more

aerovanc

PAP.Info

Visit our PAP portal for patients and relatives and connect across borders

Read more

papinfo

News & Events

19Mar, 2017

Mast Therapeutics sets date for special meeting of stockholders to vote on proposed merger with Savara

0 Comments
Special Meeting To Be Held on April 21, 2017 SAN DIEGO, CA and AUSTIN, TX – March 16, 2017 –... Read More
07Jan, 2017

Mast Therapeutics and Savara sign merger agreement

0 Comments
Proposed Merger Creates Specialty Pharmaceutical Company with Three Clinical-Stage Inhaled Product Candidates for Serious and Life-Threatening Diseases Conference Call Scheduled... Read More
Back to Top